Business
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
Leading experts to discuss advances in technologies to prevent esophageal cancer through esophageal precancer screening NEW YORK, Sept. 10, 2024 /PRNewswire/
About this update from Lucid Diagnostics Inc.
[{"type":"text","content":"Leading experts to discuss advances in technologies to prevent esophageal cancer through esophageal precancer screening\nNEW YORK, Sept. 10, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (\"Lucid\" or the \"Company\") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), announced that it will be participating as the sole Diamond Sponsor at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress being held from September 22-24, 2024, at the Edinburgh International Convention Centre in Edinburgh, Scotland. Lucid will be highlighting the unprecedented performance of its EsoGuard® Esophageal DNA Test for early detection of esophageal precancer to conference participants.\n\n \n \n \n \n \n \n\n \nLucid will also host a symposium entitled Non-Endoscopic Screening for Barrett's Esophagus chaired by distinguished experts in esophageal diseases, including Vani Konda, M.D., Medical Director of the Center for Esophageal Diseases at Baylor Scott & White Health, and Nicholas Shaheen, M.D., M.P.H., Professor and Chief of Gastroenterology & Hepatology at UNC Chapel Hill, the current ISDE President and lead author of the American College of Gastroenterology (ACG) guidelines on esophageal precancer screening. The symposium's panel discussion will include Vivek Kaul, M.D., Professor in the Division of Gastroenterology & Hepatology at the University of Rochester Medical Center, and Rehan Haidry, M.D., Consultant Gastroenterologist at Cleveland Clinic London.\n\"At Lucid, we are committed to be the leading international voice on esophageal cancer prevention though early detection of esophageal precancer and are excited to have a strong presence at this year's ISDE World Congress, a premier global event for international experts in esophageal disease,\" said Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer. \"We are particularly excited to host our first international symposium on non-endoscopic esophageal precancer screening led by renowned specialists from the United States and Great Britain. We are grateful to our longstanding collaborator, Dr. Shaheen and his esteemed colleagues Dr. Konda, Dr. Kaul, and Dr. Haidry for their invaluable contributions to the field and for leading what we believe will be an outstanding symposium.\"\nTh...